 | Up a level |
Khan, Faizan; Tritschler, Tobias; Kimpton, Miriam; Wells, Philip S; Kearon, Clive; Weitz, Jeffrey I; Büller, Harry R; Raskob, Gary E; Ageno, Walter; Couturaud, Francis; Prandoni, Paolo; Palareti, Gualtiero; Legnani, Cristina; Kyrle, Paul A; Eichinger, Sabine; Eischer, Lisbeth; Becattini, Cecilia; Agnelli, Giancarlo; Vedovati, Maria Cristina; Geersing, Geert-Jan; ... (2021). Long-term Risk of Recurrent Venous Thromboembolism Among Patients Receiving Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. Journal of thrombosis and haemostasis, 19(11), pp. 2801-2813. Wiley-Blackwell 10.1111/jth.15491
Van Mieghem, Nicolas M; Unverdorben, Martin; Valgimigli, Marco; Mehran, Roxana; Boersma, Eric; Baber, Usman; Hengstenberg, Christian; Shi, Minggao; Chen, Cathy; Saito, Shigeru; Veltkamp, Roland; Vranckx, Pascal; Dangas, George D (2018). Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial. American Heart Journal, 205, pp. 63-69. Elsevier 10.1016/j.ahj.2018.07.006
Tangelder, Marco J D; Nwachuku, Chuke E; Jaff, Michael; Baumgartner, Iris; Duggal, Anil; Adams, George; Ansel, Gary; Grosso, Michael; Mercuri, Michele; Shi, Minggao; Minar, Erich; Moll, Frans L (2015). A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention. Journal of endovascular therapy, 22(2), pp. 261-268. International Society of Endovascular Specialists 10.1177/1526602815574687
